Agnieszka Walczyk

645 total citations
34 papers, 510 citations indexed

About

Agnieszka Walczyk is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Agnieszka Walczyk has authored 34 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Agnieszka Walczyk's work include Thyroid Cancer Diagnosis and Treatment (30 papers), BRCA gene mutations in cancer (8 papers) and Thyroid and Parathyroid Surgery (6 papers). Agnieszka Walczyk is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (30 papers), BRCA gene mutations in cancer (8 papers) and Thyroid and Parathyroid Surgery (6 papers). Agnieszka Walczyk collaborates with scholars based in Poland and Canada. Agnieszka Walczyk's co-authors include Aldona Kowalska, Stanisław Góźdż, Artur Kowalik, Iwona Pałyga, Danuta Gąsior‐Perczak, Janusz Kopczyński, Tomasz Trybek, Magdalena Chrapek, Jacek Sygut and Małgorzata Chłopek and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Agnieszka Walczyk

33 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agnieszka Walczyk Poland 13 390 151 126 123 97 34 510
Iwona Pałyga Poland 13 367 0.9× 151 1.0× 109 0.9× 109 0.9× 89 0.9× 38 498
Danuta Gąsior‐Perczak Poland 13 333 0.9× 139 0.9× 101 0.8× 103 0.8× 87 0.9× 37 462
Vlasta Sýkorová Czechia 12 386 1.0× 129 0.9× 109 0.9× 143 1.2× 129 1.3× 18 501
Šárka Dvořáková Czechia 12 389 1.0× 127 0.8× 119 0.9× 141 1.1× 176 1.8× 21 527
Mariangela Sculli Italy 4 423 1.1× 103 0.7× 160 1.3× 131 1.1× 105 1.1× 5 489
Beata Jurecka‐Lubieniecka Poland 13 254 0.7× 139 0.9× 85 0.7× 59 0.5× 80 0.8× 31 465
Fernando Rodrigues Portugal 11 279 0.7× 72 0.5× 112 0.9× 90 0.7× 143 1.5× 41 437
Teresa Ramone Italy 9 297 0.8× 79 0.5× 77 0.6× 103 0.8× 53 0.5× 23 352
Kornelia Hasse-Lazar Poland 10 220 0.6× 79 0.5× 61 0.5× 44 0.4× 77 0.8× 27 352
Katherine Weber Germany 4 496 1.3× 130 0.9× 73 0.6× 82 0.7× 214 2.2× 7 553

Countries citing papers authored by Agnieszka Walczyk

Since Specialization
Citations

This map shows the geographic impact of Agnieszka Walczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnieszka Walczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnieszka Walczyk more than expected).

Fields of papers citing papers by Agnieszka Walczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnieszka Walczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnieszka Walczyk. The network helps show where Agnieszka Walczyk may publish in the future.

Co-authorship network of co-authors of Agnieszka Walczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Agnieszka Walczyk. A scholar is included among the top collaborators of Agnieszka Walczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnieszka Walczyk. Agnieszka Walczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gąsior‐Perczak, Danuta, Artur Kowalik, Janusz Kopczyński, et al.. (2024). Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with CHEK2 Germline Mutations. Cancers. 16(4). 815–815. 3 indexed citations
2.
Kowalik, Artur, Agnieszka Walczyk, Iwona Pałyga, et al.. (2023). CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer. International Journal of Molecular Sciences. 24(12). 10019–10019. 4 indexed citations
3.
Kopczyński, Janusz, Artur Kowalik, Agnieszka Walczyk, et al.. (2022). A Significance of Concomitant BRAF V600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases. Thyroid. 32(11). 1372–1381. 11 indexed citations
4.
Walczyk, Agnieszka, et al.. (2021). Late-Onset Medullary Thyroid Cancer in a Patient with a Germline RET Codon C634R Mutation. Diagnostics. 11(8). 1448–1448. 1 indexed citations
5.
Gąsior‐Perczak, Danuta, Artur Kowalik, Agnieszka Walczyk, et al.. (2021). Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma. Cancers. 13(3). 470–470. 8 indexed citations
6.
Kowalik, Artur, Agnieszka Walczyk, Iwona Pałyga, et al.. (2021). Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy. Genes. 12(10). 1534–1534. 9 indexed citations
7.
Gąsior‐Perczak, Danuta, Agnieszka Walczyk, Iwona Pałyga, et al.. (2021). Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?. Journal of Clinical Medicine. 10(11). 2438–2438. 10 indexed citations
8.
Walczyk, Agnieszka, Janusz Kopczyński, Danuta Gąsior‐Perczak, et al.. (2020). Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients. PLoS ONE. 15(2). e0229264–e0229264. 8 indexed citations
9.
Kowalik, Artur, Iwona Pałyga, Agnieszka Walczyk, et al.. (2020). Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?. Cancers. 12(2). 423–423. 5 indexed citations
11.
Trybek, Tomasz, Agnieszka Walczyk, Danuta Gąsior‐Perczak, et al.. (2019). Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer. Endocrinology. 160(10). 2328–2338. 27 indexed citations
12.
Gąsior‐Perczak, Danuta, Artur Kowalik, Agnieszka Walczyk, et al.. (2019). Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course. Cancers. 11(11). 1744–1744. 13 indexed citations
13.
Kopczyński, Janusz, Iwona Pałyga, Agnieszka Walczyk, et al.. (2019). The influence of the reclassification of NIFTP as an uncertain tumour on risk of malignancy for the diagnostic categories according to the Bethesda system for reporting thyroid cytopathology. Endokrynologia Polska. 70(3). 232–236. 5 indexed citations
14.
Gąsior‐Perczak, Danuta, Iwona Pałyga, Artur Kowalik, et al.. (2018). The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer. PLoS ONE. 13(10). e0204668–e0204668. 33 indexed citations
15.
Walczyk, Agnieszka, Janusz Kopczyński, Danuta Gąsior‐Perczak, et al.. (2018). Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor‐Node‐Metastasis Staging System (eighth edition). Clinical Endocrinology. 91(2). 331–339. 13 indexed citations
16.
Kowalik, Artur, Aldona Kowalska, Agnieszka Walczyk, et al.. (2017). Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications. PLoS ONE. 12(6). e0179691–e0179691. 11 indexed citations
17.
Kowalska, Aldona, Agnieszka Walczyk, Iwona Pałyga, et al.. (2016). The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence. PLoS ONE. 11(4). e0153242–e0153242. 22 indexed citations
18.
Kowalska, Aldona, Iwona Pałyga, Danuta Gąsior‐Perczak, et al.. (2015). The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer. PLoS ONE. 10(7). e0133852–e0133852. 24 indexed citations
19.
Kowalik, Artur, et al.. (2014). Occurrence other than V600E mutation in the BRAF gene in papillary thyroid carcinoma. Endocrine Abstracts. 1 indexed citations
20.
Walczyk, Agnieszka, Aldona Kowalska, & Jacek Sygut. (2011). The clinical course of poorly differentiated thyroid carcinoma (insular carcinoma) - own observations.. PubMed. 61(5). 467–73. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026